Skip to main content
Clinical Trials/NCT00706277
NCT00706277
Completed
Phase 4

Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function

Medical University Innsbruck1 site in 1 country60 target enrollmentJune 2008

Overview

Phase
Phase 4
Intervention
propofol
Conditions
Lung Function
Sponsor
Medical University Innsbruck
Enrollment
60
Locations
1
Primary Endpoint
FEV1 forced expiratory volume; FVC forced vital capacity
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

The aim of the study is to investigate the effects of total intravenous anesthesia (TIVA; propofol, remifentanil) and balanced anesthesia (BAL; induction with propofol and fentanyl; maintenance of anesthesia with sevoflurane and nitrous oxide) on pulmonary function 30 minutes after emergence from the general anesthesia.

Registry
clinicaltrials.gov
Start Date
June 2008
End Date
December 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Medical University Innsbruck

Eligibility Criteria

Inclusion Criteria

  • BMI normal

Exclusion Criteria

  • lung disease
  • Nicotine abuse

Arms & Interventions

TIVA

patients receiving total intravenous anesthesia (TIVA)

Intervention: propofol

TIVA

patients receiving total intravenous anesthesia (TIVA)

Intervention: remifentanil

balanced

patients receiving balanced anesthesia

Intervention: propofol

balanced

patients receiving balanced anesthesia

Intervention: fentanyl

balanced

patients receiving balanced anesthesia

Intervention: Sevoflurane/Nitrous Oxide

Outcomes

Primary Outcomes

FEV1 forced expiratory volume; FVC forced vital capacity

Time Frame: preoperative, 30 minutes postoperative

Study Sites (1)

Loading locations...

Similar Trials